EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases

Anahi V Odell1,2, Nathan M Newton1,2,3, Anna Eisenstein1

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.

Nature Communications
|October 9, 2025
PubMed

Insights

Fibroblast STAT1 signaling, driven by EGFR, is crucial for skin fibrosis in chronic inflammatory skin diseases. Inhibiting this pathway offers a potential therapeutic strategy for these difficult-to-treat conditions.

Area of Science:

  • Dermatology
  • Immunology
  • Molecular Biology

Background:

  • Chronic inflammatory skin diseases, particularly those involving fibrosis, present significant therapeutic challenges.
  • The molecular signals dictating fibrotic progression in skin inflammation remain largely unelucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying fibrosis in chronic inflammatory skin diseases.
  • To identify key signaling pathways and cellular components involved in fibrotic skin disease pathogenesis.

Main Methods:

  • Generation of a single-cell RNA sequencing (scRNA-seq) atlas comparing seven inflammatory skin diseases with healthy controls.
  • In vivo studies using mouse models to assess the role of fibroblast STAT1 in skin fibrosis.
  • Investigating the interplay between EGFR, STAT1, and fibrotic gene expression.

Main Results:

  • Fibrotic skin diseases exhibit elevated STAT1 expression and activity in fibroblasts.
  • Fibroblast-specific STAT1 is essential for the development of skin fibrosis in mice.
  • EGFR directly activates STAT1 in a JAK-independent manner, promoting a fibrotic gene expression profile.
  • Keratinocyte-derived EGFR ligands stimulate the EGFR-STAT1 pathway, suggesting a role in initiating fibrosis.

Conclusions:

  • The EGFR-STAT1 signaling axis in fibroblasts is a key mediator of fibrotic gene expression in fibroinflammatory skin diseases.
  • This study reveals an interferon-independent function of STAT1 in driving fibrotic skin conditions.
  • Targeting the EGFR-STAT1 pathway presents a potential therapeutic avenue for refractory fibrotic skin diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.8K